Bladder cancer study questions whether chemo skews MRI results

NCT ID NCT07202819

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This trial is investigating whether chemotherapy given before bladder removal surgery affects how accurate MRI scans are at staging muscle-invasive bladder cancer. Researchers will compare MRI results with actual tumor findings after surgery in 76 participants who either received chemo first or went straight to surgery. The goal is to understand if chemo-induced tissue changes make MRI less reliable.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Neoadjuvant chemotherapy (cisplatin-based regimens such as MVAC or gemcitabine and cisplatin)
What this could lead to
If successful, this study could help doctors know whether MRI scans remain reliable for staging bladder cancer after chemotherapy, improving treatment planning.
What could go wrong
This is a small, early-stage study focused on diagnostic accuracy, not a treatment. Results may not apply to all patients or change clinical practice directly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MUSCLE-INVASIVE BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Urology Department, Faculty of Medicine, Assiut University

    NOT_YET_RECRUITING

    Asyut, Asyut Governorate, 71515, Egypt

  • Urology Department, Faculty of Medicine, Assiut University

    RECRUITING

    Asyut, Asyut Governorate, 71515, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.